PROTIVA BIOTHERAPEUTICS, INC.
Patent Owner
Stats
- 46 US PATENTS IN FORCE
- 5 US APPLICATIONS PENDING
- Mar 15, 2018 most recent publication
Details
- 46 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 8,130 Total Citation Count
- Feb 02, 1999 Earliest Filing
- 23 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0071,397 NOVEL LIPID FORMULATIONS FOR DELIVERY OF THERAPEUTIC AGENTS TO SOLID TUMORSNov 20, 17Mar 15, 18[A61K, C12N]
2017/0151,333 NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOFSep 09, 16Jun 01, 17[A61K, C07D, C07C]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9878042 Lipid formulations for delivery of therapeutic agents to solid tumorsJan 27, 15Jan 30, 18[C07H, A61K, C12N]
9765333 Compositions and methods for silencing marburg virus gene expressionAug 21, 15Sep 19, 17[A61K, C12N]
9428751 Compositions and methods for silencing apolipoprotein C-III expressionApr 01, 15Aug 30, 16[A61K, C07H, B82Y, C12N]
9222086 Compositions and methods for silencing genes expressed in cancerSep 23, 10Dec 29, 15[A61K, C07H, C12Q, C12N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0042,814 NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERYAbandonedMay 25, 16Feb 16, 17[A61K, C12N]
2016/0256,567 COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNAAbandonedMay 12, 16Sep 08, 16[A61K]
2016/0256,568 COMPOSITIONS AND METHODS FOR DELIVERING MESSENGER RNAAbandonedMay 12, 16Sep 08, 16[A61K]
2014/0288,146 NOVEL TRIALKYL CATIONIC LIPIDS AND METHODS OF USE THEREOFAbandonedApr 25, 13Sep 25, 14[A61K, C07C]
2013/0178,511 SILENCING OF CSN5 GENE EXPRESSION USING INTERFERING RNAAbandonedJul 17, 12Jul 11, 13[C12N]
2013/0122,104 NOVEL LIPID FORMULATIONS FOR DELIVERY OF THERAPEUTIC AGENTS TO SOLID TUMORSAbandonedAug 03, 12May 16, 13[A61K]
2013/0123,338 NOVEL CATIONIC LIPIDS AND METHODS OF USE THEREOFAbandonedMay 12, 11May 16, 13[A61K, C07D, C07C]
2012/0058,188 LIPID ENCAPSULATED INTERFERING RNAAbandonedJun 24, 11Mar 08, 12[A61K, B82Y, C12N, A61P]
2011/0313,017 SNALP FORMULATIONS CONTAINING POLYOXAZOLINE-DIALKYLOXYPROPYL CONJUGATESAbandonedJan 13, 11Dec 22, 11[A61K, C12N]
2011/0177,131 siRNA SILENCING OF FILOVIRUS GENE EXPRESSIONAbandonedSep 09, 10Jul 21, 11[A61K, C07H, B82Y, A61P]
2011/0071,208 LIPID ENCAPSULATED DICER-SUBSTRATE INTERFERING RNAAbandonedJun 04, 10Mar 24, 11[A61K, C12N, A61P]
2008/0171,716 NUCLEIC ACID MODULATION OF TOLL-LIKE RECEPTOR-MEDIATED IMMUNE STIMULATIONAbandonedAug 15, 07Jul 17, 08[A61K, C07H, A61P]
2007/0218,122 siRNA silencing of influenza virus gene expressionAbandonedNov 17, 06Sep 20, 07[A61K, C07H]
2007/0054,873 Glucocorticoid modulation of nucleic acid-mediated immune stimulationAbandonedAug 28, 06Mar 08, 07[A61K]
2006/0051,405 Compositions for the delivery of therapeutic agents and uses thereofAbandonedJul 19, 05Mar 09, 06[A61K, C12N]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
